IPSWICH, Mass. — April 1, 2025 —. EBSCO Clinical Decisions is pleased to announce the availability of Dyna AI for individual subscribers of DynaMedex®. Leveraging generative artificial intelligence, Dyna AI delivers evidence-based information to clinicians at the point of care with unprecedented speed and accuracy, now accessible without an institutional subscription. Available on any device, Dyna AI ensures clinicians receive reliable and trusted answers whenever and wherever they need them. Initially launched in July 2024, the mobile capability was introduced in October 2024.
EBSCO Clinical Decisions is at the forefront of transforming clinical decision-making, addressing the growing demand for rapid access to high-quality clinical information. By responsibly deploying generative AI, EBSCO Clinical Decisions addresses modern challenges like cognitive overload and clinician burnout. Dyna AI revolutionizes the industry by offering concise, actionable clinical answers with clear citations of expert-curated, evidence-based information exclusively available from EBSCO Clinical Decisions. Tailored to meet the needs of today’s clinicians, Dyna AI for DynaMedex provides a personalized approach, empowering users to swiftly access the most accurate and relevant information wherever and however they need. This update allows individual clinicians to access trusted DynaMedex information at AI speed, without an institutional subscription.
Since the release of Dyna AI for Dynamic Health and DynaMedex in July 2024, we have worked to communicate the important role that Dyna AI can play at the point of care.
Since the release of Dyna AI for Dynamic Health and DynaMedex in July 2024, we have worked to communicate the important role that Dyna AI can play at the point of care.
Julia Colpitts, Senior Vice President of Clinical Strategy & Commercial Excellence at EBSCO Clinical Decisions, highlights that Dyna AI supports clinicians at the point of care by alleviating the burden of information search, and instead quickly surfacing the answers they need. “Since the release of Dyna AI for Dynamic Health and DynaMedex in July 2024, we have worked to communicate the important role that Dyna AI can play at the point of care. Dyna AI ensures that clinicians can get the evidence-based, expert-curated information they need quicker than ever before.”
Individual clinicians in the United States can experience Dyna AI with a free limited trial. Discover more about Dyna AI and how it can transform your clinical practice.
About EBSCO Information Services
EBSCO Information Services (EBSCO) is a leading provider of online research content and cutting-edge search technologies serving libraries, healthcare and medical institutions, corporations, and government agencies worldwide. As an AI-enabled services leader, EBSCO offers comprehensive solutions from research, acquisition management, subscription services and discovery services to clinical decision support and patient care, learning, and research and development, EBSCO provides institutions with access to content and resources to serve the information and workflow needs of their users and organizations. The EBSCO Clinical Decisions suite of products is designed to improve patient care by providing healthcare professionals with the most current, evidence-based answers to clinical questions as they arise at the point of care. Our commitment to AI-driven innovation positions EBSCO at the forefront of the industry, enabling us to meet the evolving needs of the information services landscape. For more information, visit the EBSCO website at: www.ebsco.com. Visit our blog at EBSCOpost or follow us on X, Facebook, LinkedIn and Instagram.
###
For more information, please contact:
Briana Peters
Communications Specialist
bpeters@ebsco.com
978-414-0277
